// App-Quantinova.ai

5158 : The change of EZH2 expression in development of colorectal cancer from adenoma

Researchers

Presenter

  • Mayuko Ohuchi

Principal Investigators

  • Yasuo Nakamoto

  • Ryuma Tokunaga

  • Kenichi Nakamura

  • Keisuke Kosumi

  • Kazuto Harada

  • Hironobu Shigaki

  • Junji Kurashige

  • Masaaki Iwatsuki

  • Yoshifumi Baba

  • Yuji Miyamoto

  • Naoya Yoshida

  • Hideo Baba

Medical Centers

  • Kumamoto Univ., Kumamoto, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

  • Intraductal papillary mucinous neoplasm

Biomarkers

  • p53

  • Polycomb repressive complex 2

  • Enhancer of zeste homolog 2

  • KRAS proto-oncogene, GTPase

  • Deleted in colorectal cancer

Drug/Treatment

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved